Drug Topics

JANUARY 16, 2023

Pharmaceutical makers, price managers out of control with ‘necessary drug’ for millions, Attorney General says.

187

187

Pharmacy Times

JANUARY 16, 2023

The head of the CAR T cell antibody can recognize and target the growth factor in its tumor microenvironment.

FDA 162

FDA 162

Drug Topics

JANUARY 16, 2023

High drug prices, supply chain issues, and inflation are just a few challenges chipping away at prescription drug profits. But enhanced procurement strategies enable pharmacies to drive profitability. Read our latest white paper, “How to Maximize Prescription Drug Profits in Today's Purchasing Environment”. Profitability is how you sustain your business so you can continue to serve patients.

98

98

Pharmacy Times

JANUARY 16, 2023

Clonidine works on adrenergic receptors in the brain, which are known for their role in fight-or-flight responses and are believed to be activated in post-traumatic stress disorder.

123

123

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmaceutical Technology

JANUARY 16, 2023

While the biopharmaceutical industry has been impacted and pressured by various factors such as the Covid-19 pandemic, inflation, the Ukraine-Russia war, ongoing supply chain issues, and a challenging economic environment, collaboration between pharma companies and emerging technologies providers continues to grow, especially in the research and development (R&D) field, offering some resilience in times of geopolitical and economic disruptions.

Pharmaceutical Companies 121

Pharmaceutical Companies Pharmaceutical Companies Vaccines 121

Pharmacy Times

JANUARY 16, 2023

If patients attend their discharge appointments at pharmacist-led heart failure transition of care clinics, they are less likely to be readmitted to the hospital within 30 days.

Hospitals 122

Hospitals 122

Pharmacy Times

JANUARY 16, 2023

Ronna Hauser of the National Community Pharmacists Association and Olin and Scotty Sykes, accountants from Sykes & Company, discuss DIR changes.

132

132

European Pharmaceutical Review

JANUARY 16, 2023

A Mutual Recognition Agreement (MRA) relating to pharmaceutical Good Manufacturing Practice (GMP) has been signed between Switzerland and the US. Under the agreement with the Swiss Confederation (Switzerland), the Swiss Agency for Therapeutic Products (Swissmedic) and the US Food and Drug Administration (FDA) will be able to utilise each other’s GMP inspections of pharmaceutical manufacturing facilities, avoiding the need for duplicate inspections.

FDA 111

FDA 111

Pharmacy Times

JANUARY 16, 2023

Providers use "Kitchen Sink Approach" because cure proves elusive, symptomatic treatment is sketchy.

158

158

pharmaphorum

JANUARY 16, 2023

Regulatory authorities in the US are investigating a possible link between the new Pfizer/BioNTech bivalent COVID-19 booster vaccine and strokes in people aged 65 or over, but still recommend the shots. Monitoring has pointed to a possible higher risk of ischaemic stroke in the 21-day period post-vaccination in this age group compared to 22 to 44 days post-vaccination, according to an announcement on the Centre for Disease Control and Prevention (CDC) website. “Although the totality of the

Vaccines 108

Vaccines Hospitals FDA 108

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

JANUARY 16, 2023

Label update removes a previous limitation that stated the medication should not be used as initial therapy for treating patients with type 2 diabetes.

Labelling 123

Labelling FDA 123

STAT

JANUARY 16, 2023

They’re far too small to be seen by even the most sophisticated medical imaging device. But bits of tumor DNA adrift in a patient’s blood are an important bellwether for whether cancer will return — and, as a new study shows, can predict which treatments are likely to work. Scientists reported in the journal Nature Medicine on Monday that colorectal cancer patients who had tumor DNA in their blood after surgery were far more likely to have their cancer return.

Chemotherapy 104

Chemotherapy 104

Pharmacy Times

JANUARY 16, 2023

Study is the first to examine calciferol in brain tissue, which may help investigators understand dementia and its causes.

132

132

STAT

JANUARY 16, 2023

SAN FRANCISCO — Invitae, a Bay Area genetic testing company with a mission to use genomic information to improve health care, has struggled to turn that mantra into a solid business model. It’s now trying to turn things around. The company, which offers genetic tests for people who are pregnant or planning to have a child as well as for conditions such as heart disease and hereditary cancers, announced last July that it would lay off more than 1,000 employees , more than a third of

98

98

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

JANUARY 16, 2023

The atypical antipsychotic is an extended-release injectable suspension that is administered bi-weekly.

FDA 139

FDA 139

Digital Pharmacist

JANUARY 16, 2023

Creating a 2023 health awareness calendar this year is a great way to market your pharmacy while promoting patient health. . Benefits of Creating a 2023 Health Awareness Calendar: Every month, national organizations and countries around the world come together to share educational content and promote services that support specific health conditions.

Immunization 98

Immunization Vaccines Communication Hospitals 98

Pharmacy Times

JANUARY 16, 2023

Recommendations vary based on age, first vaccination received, and time since the last dose.

Vaccines 139

Vaccines 139

BioPharm

JANUARY 16, 2023

The agreement will be able to let FDA and the Swiss Agency for Therapeutic Products (Swissmedic) utilize each other’s GMP inspections of manufacturing facilities, avoiding the need for duplicate inspections.

FDA 89

FDA 89

Pharmacy Times

JANUARY 16, 2023

Significant study results may help inform clinical practice strategies.

141

141

Drug Topics

JANUARY 16, 2023

Natasha A. Mesinkovska, MD, PhD, shares what’s new in alopecia areata management.

98

98

Pharmacy Times

JANUARY 16, 2023

Analysis focuses on why some individuals with a genetic predisposition develop AMD, while others are spared.

149

149

Pharmafile

JANUARY 16, 2023

Eli Lilly and AbbVie have announced their departure from the voluntary scheme for branded medicines pricing and access (VPAS), causing worry that NHS patients may miss out on breakthrough drug treatments. VPAS is an agreement which was set up in 2019 between the Government, NHS and medicine manufacturers designed to limit the cost of drugs for the health service while supporting industry innovation.

Communication 73

Communication 73

pharmaphorum

JANUARY 16, 2023

Hormone replacement therapy (HRT) could cut the risk of Alzheimer’s in some women at elevated risk of the disease, according to researchers in the UK. The study by a team at the Universities of East Anglia and Edinburgh shows that HRT use is associated with better memory, cognition, and larger brain volumes in later life among women carrying the APOE4 gene, a well-established risk factor for Alzheimer’s.

73

73

Drug Topics

JANUARY 16, 2023

New approvals include gene therapies, first-in-class drugs, treatments for rare diseases, and cancer, as well as biosimilars.

FDA 76

FDA 76

pharmaphorum

JANUARY 16, 2023

Two top pharma companies have exited the UK’s voluntary medicines pricing agreement in protest at what the industry has said is a “punitive” system of revenue clawbacks, casting doubt on the future of the scheme in its present form. AbbVie and Eli Lilly have left the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS), according to an update issued this morning by the Association of the British Pharmaceutical Industry (ABPI), which said the move has “sent a w

67

67

Pharmacy Times

JANUARY 16, 2023

YLB113 (Nepexto) produced significantly lower injection site reactions and injection site erythema compared with etanercept in patients with rheumatoid arthritis.

65

65

OctariusRx

JANUARY 16, 2023

This week we are once again providing an update on the most recent drug shortages. Drug shortages currently remain at over 100 different medications, with the Food and Drug Administration (FDA) noting 123 products as being unavailable. Some of these shortages are short term, or limited availability, while others are completely unavailable with unknown release dates.

Long-Term Care Facilities 66

Long-Term Care Facilities FDA 66

Outsourcing Pharma

JANUARY 16, 2023

A Florida doctor has been sent to prison after submitting a false affidavit claiming she had screened children in a clinical study looking at the effectiveness of drugs given to children with asthma when she had not.

FDA 59

FDA 59

PharmaVoice

JANUARY 16, 2023

After years of pioneering new methods for using data and technology to improve patient health outcomes, IQVIA’s Christina Mack is on the cusp of a research revolution.

59

59

Outsourcing Pharma

JANUARY 16, 2023

AMR joins a Series C funding raise for BioVersys, which is developing antimicrobials against common drug-resistant bacteria that threaten public health.

59

59

The Checkup by Singlecare

JANUARY 16, 2023

Is Glyxambi covered by insurance? | How much does Glyxambi cost without insurance? | How to get Glyxambi without insurance. Glyxambi (empagliflozin-linagliptin) is a brand-name prescription combination drug that helps to lower blood sugar levels in people with Type 2 diabetes. It should not be used to treat those with Type 1 diabetes or diabetic ketoacidosis.

Insurance 52

Insurance FDA 52

Hospital Pharmacy Europe

JANUARY 16, 2023

A molecular diagnostic aid provides reliable and fast respiratory pathogen identification in mechanically ventilated children with pneumonia. A diagnostic aid which uses polymerase chain reactions (PCR) with a 52-pathogen custom array card, provides rapid (compared to blood culture) and reliable information on respiratory infections in critically ill, mechanically ventilated children with community or hospital-acquired pneumonia according to a study by UK researchers.

Hospitals 52

Hospitals 52

Roots Analysis

JANUARY 16, 2023

In the health industry, digitization has evolved over time with numerous advances to ensure that everyone has equitable access to health products and medical specialists. At-home Self-testing has the ability to improve health equity and accelerate progress toward universal health coverage, and it has the capacity to alter health care. Self-testing alternatives provide individuals and communities with simple, quick, and private means to diagnose and treat a rising range of diseases, including HIV

52

52

Hospital Pharmacy Europe

JANUARY 16, 2023

Lebrikizumab targets interleukin (IL)-13 and in combination with topical steroids appears effective in moderate to severe atopic eczema. Lebrikizumab used alongside low to mid-potency topical corticosteroids is an effective treatment option for adults with moderate to severe atopic eczema according to the findings of a randomised, placebo-controlled trial by an international research group.

Hospitals 52

Hospitals 52